Loading organizations...
Harbor Light Capital Partners is a venture capital firm based in Keene, New Hampshire, providing patient capital to early-stage and growth-stage companies in the healthcare and technology sectors. The firm functions as an engaged board member, leveraging its network across New England and the Intermountain West to support portfolio development, positioning itself as a lifecycle investor. Operating with fewer than 25 employees and generating under $5 million in revenue, Harbor Light Capital focuses on building sustainable, high-growth businesses without strict time horizon constraints. Its portfolio includes companies like Alcyone Lifesciences, Anuncia, Carmell Therapeutics, and Medicinal Genomics Corp, with a notable past exit being Home Diagnostics, Inc. (acquired by Nipro Corporation). Harbor Light Capital Partners was founded in 2008 by Richard Upton, a co-founder with a background in healthcare investment banking.
Harbor Light Capital has 4 tracked investments across 3 companies. The latest tracked deal is $4.0M Series B in Carmell Therapeutics in July 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 12, 2017 | Carmell Therapeutics | $4.0M Series B | — | Bluetree Capital, Keiretsu Capital, Newlin VC, Pittsburgh Life Sciences Greenhouse |
| Jun 22, 2015 | Senet | $18.0M Series A | — | City Light Capital, Fisk Ventures, Richard J. Dumler |
| Jan 15, 2014 | Alcyone Lifesciences | $4.0M Series B | Edgar D. Jannotta, JR. | — |
| Apr 15, 2011 | Carmell Therapeutics | $3.0M Series A | Harbor Light Capital | Ariel Southeast Angel Partners, BlueTree Allied Angels, Innovation Works, Newlin Investment Company, Pittsburgh Life Sciences Greenhouse |
